Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
91 Cards in this Set
- Front
- Back
2 primary forms of ischemic heart ds |
angina pectoris MI |
|
prinzmetals angina |
due to acute coronary vasospasm and often occurs during rest or sleep. |
|
what do beta blockers do for MI and angina patients |
i. beta blockers can improve distribution of coronary flow by reducing intraventricular pressure |
|
2 goals of tx for angina |
increase O2 supply and decrease O2 demand. |
|
angina vs variant angina treatments |
typical angina tx with vasodilators and beta blockers to decrease O2 demand. Variant angina use vasodilators to increase O2 supply by relaxing coronary smooth muscle and restoring normal coronary flow. Beta blockers don't work as well because they do not counteract vasospasm. |
|
what are the modifiable risk factors with angina |
HTN. hyperlipidemia. DM. smoking cessation. |
|
first line for angina tx |
beta blockers |
|
HTN, CHF, typical angina, MI, certain arrhythmias, migraines are all indications for what drug? |
beta blockers |
|
contraindications for beta blockers |
sinus brady (<60), SBP <100, heart block, cardiogenic shock, ADHF. Non-selective agents are contraindicated for COPD, asthma and DM. |
|
DDI's of beta blockers |
verapamil which has the greatest potential for reducing contractility and decreasing CO. |
|
beta specific and or cardioselective |
metoprolol. atenolol. Nebivolol. |
|
non selective beta blockers |
nadolol and propranolol |
|
alpha 1 and beta blockers |
carvedilol and labetalol. |
|
pregnancy category of beta blockers |
C/D |
|
pregnancy category for CCB's |
C |
|
MOA for CCB's |
bind calcium ion channels in smooth muscle and cardiac tissue that leads to smooth muscle relaxation and suppression of cardiac activity which leads to O2 demand decreases. |
|
Indications of CCB's |
HTN, angina, arrhythmias. especially variant angina with diltiazem and verapamil |
|
contraindications for CCB's |
mostly for non DHP. SBP <100, HR <60, ADHF, EF < 40%., AV block. |
|
ADR's of CCB's |
constipation, fatigue, headache, flushing, dizziness, hypotension, bradycardia, reflex tachycardia, edema. |
|
Role of CCB's in angina |
Use Non-DHPs as initial therapy when BBs are contraindicated. Use DHPs as add on therapy to BBs. Use in combo w/ nitrates. Non-DHP preferred for variant angina |
|
non-DHP CCB's |
verapamil and diltiazem. |
|
DHP CCB's |
amlodipine. felodipine. nifedipine (avoid IR formulation) |
|
DHP vs non-DHP CCB's MOA? |
DHP work more on the vascular smooth muscle to reduce BP. Non-DHP work more on the cardiac tissue reducing the HR and BP. |
|
what happens to the dose of nitrates over time? |
it may need to increase because the patient can build tolerances. |
|
MOA of organic nitrates |
release of nitric oxide which leads to diffusion into vascular smooth muscle cells forming cyclic GM and venous dilation leading to venous pooling decreasing preload and decreasing ventricular diastolic volume and decreasing myocardial O2 demands. |
|
MOA of organic nitrates at higher doses |
arterial dilation leading to decreased PVR and decrease in left ventricular ejection pressure which is afterload. |
|
indications for organic nitrates |
angina, MI, CHF |
|
contraindications of organic nitrates |
aortic valve stenosis. concurrent use with sildenafil, vardenafil, tadalafil. Angle-closure glaucoma, head trauma or cerebrospinal hemorrhage, severe anemia and severe hypotension SBP <90. |
|
ADR's of organic nitrates |
HA, dizziness, weakness, postural hypotension, rash, tolerance, and anxiety. |
|
organic nitrates OD s&s |
reflex tachycardia and arrhythmias. |
|
DDI's of organic nitrates |
PDE 5 inhibitors like sildenafil, tadalafil, and vardenafil. Isosorbide is CYP3A4 |
|
role in angina management with organic nitrates |
SL formulation to relieve acute symptoms of MI. SL/PO to prevent effort induced angina (prophylactically). Long acting formulations for maintenance therapy |
|
indications for amyl nitrate? route? |
cyanide poisoning. inhaled. |
|
what medication deteriorates in sunlight? |
organic nitrates |
|
how often do nitrates need replacing? |
every 3 to 6 months from when the bottle is opened. |
|
what special consideration needs to be considered when giving nitro IV? |
nitro tubing is required because nitro contains propylene glycol and will break down normal tubing. |
|
isosorbide pregnancy category |
C |
|
isosorbide given how often |
give TID at 8am, 1pm, and 6pm. |
|
how often to give nitro |
PO. must be administered QD or BID only to minimize tolerance |
|
Ranolazine MOA |
sodium current inhibitor |
|
indications for Ranolazine |
Used for chronic stable angina in combination with CCB, beta-blockers or nitrates. |
|
indications of Ranolazine |
Used for chronic stable angina in combination with CCB, beta-blockers or nitrates. |
|
Contraindications Ranolazine |
pre-existing QT prolongation, uncorrected hypokalemia, hepatic failure, if taking drugs that prolong QT interval or drugs that are potent CYP3a4 inhibitors. |
|
Ranolazine precautions |
can prolong QT interval and induce torsades de pointes. |
|
Ranolazine ADR's |
dizziness,headache, constipation. Less effects on HR and BP than other classes. Prolongs QT interval |
|
DDI's Ranolazine |
CYP450 |
|
aspirin MOA |
inhibits synthesis of prostacyclin and thromboxane A2 leading to prevent platelet aggregation leading to decreased thrombosis. |
|
aspirin role in angina |
primarily used to prevent ACS in patients with unstable angina. |
|
what are clopidogrel, prasugrel, ticagrelor |
Antiplatelet agents P2Y-12 |
|
ACE inhibitors role in angina |
use all patients with CAD to help delay progression of CAD. Do not relieve angina symptoms because do not directly affect O2 supply. |
|
consideration with concomitant diseases like DM. How to tx angina? |
non-DHP CCB most preferred, nitrates/cardioselective BB are alternatives. |
|
consideration with concomitant diseases like asthma. How to tx angina? |
non-DHP CCB or cardioselective BB most preferred. |
|
consideration with concomitant diseases like heart failure. How to tx angina? |
BB's and nitrates most preferred, non-DHP CCB least preferred |
|
consideration with concomitant diseases like HTN. How to tx angina? |
BB and non-DHP CCB most preferred |
|
consideration with concomitant diseases like prior MI. How to tx angina? |
BB most preferred |
|
consideration with concomitant diseases like bradycardia. How to tx angina? |
DHP CCB preferred |
|
consideration with concomitant diseases like heart block . How to tx angina? |
DHP CCB preferred |
|
goals of STEMI therapy |
limit infarct size. reperfuse obstructed coronary arteries. reduce morbidity and mortality. prevent post MI complications |
|
aspirin with STEMI |
162 to 325 mg stat then 81 to 325 mg QD. |
|
morphine for MI |
2 to 4 mg IV every 5 minutes with some patients requiring higher doses up to 25 t 30 mg. |
|
what medication is Recommended for all post-MI patients with substantial left ventricular dysfunction and/or clinical CHF? |
Ace inhibitors |
|
what medication is Recommended To start IV dose ASAP and continue post MI with PO doses unless contraindicated |
beta blockers |
|
what do beta blockers do for post MI |
Reduction In morbidity and mortality - immediate beta-blocker therapy appears to reduce (1) the magnitude of infarction and incidence of associated complications in subjects not receiving concomitant thrombolytic therapy and (2) the rate of reinfarction in patients receiving thrombolytic therapy. |
|
what do CCB's do for post MI patients |
a. Controversial in MI – do NOT affect morbidity and mortality. b. Maybe given to pts intolerant to beta-blockers. |
|
when would diltiazem be given to post MI patient |
Diltiazem – may be useful in pts w/ non-Q-wave MI without LV dysfunction. |
|
anticoagulants post MI are? |
a. Weight-based Unfractionated heparin. b. Low Molecular weight heparins. c. Bivalirudin. d.Fondaparinux . |
|
P2Y-12 Inhibitors are what? |
antiplatelet agents |
|
what are fibrinolytics for? |
Fibrinolytics are used to achieve rapid thrombolysis. Usually used in institutions without PCI capability or if patient cannot be transferred to an institution with PCI capability. Fibrinolytic therapy provides a survival benefit for patients with acute MI. |
|
absolute contraindications of fibrinolytics in patients with MI's |
Previous hemorrhagic stroke - Other strokes or CVA within 1 year - Intracranial neoplasm - Suspected aortic dissection |
|
relative contraindications of fibrinolytics in patients with MI's |
Severe uncontrolled HTN (> 180/110) - Recent trauma, head trauma or major surgery - Recent internal bleeding - Pregnancy - Active peptic ulcer - History of chronic severe HTN |
|
when should statins be started post MI |
9. Patient should be started on statins post-MI if not already receiving for long term reduction in CV events,morbidity and mortality |
|
1. STEMI patients:If present to hospital w/ PCI capability, they should be treated with primary PCI (stent placement) within how many minutes of first medical contact? |
90 |
|
If present to hospital w/o PCI capability and cannot be transferred to PCI center within how many minutes, they should be treated with fibrinolytics within how many minutes of hospital presentation unless contraindicated (Class IB rec) |
90 and 30 |
|
PCI – stent placement (some pts require CABG therapy. If CABG therapy indicated, antiplatelets should be held for how many days if possible. |
5 to 7 |
|
Is it better to have the heart in longer systole or longer diastole in MI? |
longer diastole |
|
what can I tell my patients to do in the winter to prevent vasospasm? |
breath warmed air, so use a face mask outside. |
|
Describe what kind of nitro should you prescribe? |
the ones that are in a foil container that can contain one per punch out pouch. |
|
Ismo isosorbide given how often |
BID – give 7 hrs apart need more of it |
|
mononitrate form – available PO only. Mononotrae is a longer acting metabolite of dinitrate form. |
mononitrate form – available PO only. Longer acting metabolite of dinitrate form. |
|
how often to give nitro over 15 minutes |
every 5 minutes take one 3 times. |
|
isosorbide imdu given how often |
once daily |
|
giving a pt a single 81mg dose of aspirin can reduce chance of cardiac event by how much? |
30% |
|
clopidogrel MOA |
works on ADP to inhibit platelet aggregation. |
|
Ticagrelor for UA are more potent than what? |
clopidogrel |
|
what 2 antiplatelet meds do you give for unstable angina |
Prasugrel Ticagrelor |
|
give what to people quitting smoking to make them happy people quitting smoking? |
wellbutrin |
|
how to chew nicotine gum |
give it 4 or 5 chews then put it in the cheek. |
|
beta blockers are 1A in clinical research to reduce morbidity and mortality. True or false |
true |
|
we don't use fibrinolytics in N-STEMI, true or false? You get what from this? |
True white thrombus which is just platelets |
|
storage considerations of nitro |
UV light breaks it down. Keep it out of the sun and in a cool dry place otherwise you could pop 20 and get no response. |
|
Immediate release forms of this med and other short-acting CCBs have increased risk of MI, CHF and death due to coronary heart disease. |
nifedipine |